Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

1.05
Delayed Data
As of 3:51pm ET
 -0.05 / -4.55%
Today’s Change
0.95
Today|||52-Week Range
6.67
-50.00%
Year-to-Date

Today’s Trading

Previous close1.10
Today’s open1.10
Day’s range1.05 - 1.10
Volume222,245
Average volume (3 months)348,147
Market cap$34.1M
Dividend yield--
Data as of 3:51pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-13.22%
Earnings growth (this year)+32.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+21.82%
P/E ratioNM
Price/Sales166.87
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
CDNACareDx Inc+0.02+1.61%
ONCSOncoSec Medical Inc-0.03-2.15%
--BARD1 Life Sciences ...-0.00-4.35%
TROVUTrovagene Inc0.000.00%
Data as of 3:51pm ET, 03/28/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$381.1K
Annual profit (last year)-$39.2M
Net profit margin-10,287.75%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Bill Welch
Vice President-Finance &
Administration
Elizabeth Anderson
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs